Editas Medicine EDIT
NASDAQ EDIT
$2.59 +0.08 (+3.19%)
At close: Sep 29, 2026 · 4:00 PM EDT

Editas Medicine (EDIT) Interest Expenses (2025)

Updated

Editas Medicine's Interest Expenses was $2.4 million in Q3 2025, up 18.8% from the prior quarter.

Analysis

Editas Medicine (EDIT) Interest Expenses (2025) Analysis & Trends

On a trailing twelve-month basis, Editas Medicine's Interest Expenses was $6.64 million through Sep 30, 2025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 281.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -435.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 247.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Editas Medicine 234.09 Mn -477.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.40 Mn
Jun 30, 2025 2.02 Mn
Mar 31, 2025 2.22 Mn
API Access

Editas Medicine Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=EDIT&period=max&api_key=YOUR_API_KEY